These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
136 related items for PubMed ID: 2869818
21. Putative mechanisms of action of tacrine in Alzheimer's disease. Adem A. Acta Neurol Scand Suppl; 1992; 139():69-74. PubMed ID: 1384265 [No Abstract] [Full Text] [Related]
32. [Effects of amiridin and tacrine, drugs effective in Alzheimer's disease, on synaptosomal uptake of neuromediators]. Burov IuV, Baĭmanov TD, Maĭsov NI. Biull Eksp Biol Med; 1992 Apr; 113(4):379-81. PubMed ID: 1356507 [Abstract] [Full Text] [Related]
33. Monoaminergic neurotransmitter alterations in postmortem brain regions of depressed and aggressive patients with Alzheimer's disease. Vermeiren Y, Van Dam D, Aerts T, Engelborghs S, De Deyn PP. Neurobiol Aging; 2014 Dec; 35(12):2691-2700. PubMed ID: 24997673 [Abstract] [Full Text] [Related]
34. Neurotransmitter correlates of impulsive aggression in humans. Coccaro EF. Ann N Y Acad Sci; 1996 Sep 20; 794():82-9. PubMed ID: 8853594 [No Abstract] [Full Text] [Related]
35. The neurochemistry of Alzheimer's disease. Engelborghs S, De Deyn PP. Acta Neurol Belg; 1997 Jun 20; 97(2):67-84. PubMed ID: 9246374 [Abstract] [Full Text] [Related]
36. Causes of cell damage in hypoxia/ischemia, aging and Alzheimer's disease. Gibson G. Neurobiol Aging; 1989 Jun 20; 10(5):608-9; discussion 618-20. PubMed ID: 2812237 [Abstract] [Full Text] [Related]
37. Significance of neurotransmitter abnormalities in Alzheimer's disease. Katzman R, Brown T, Fuld P, Thal L, Davies P, Terry R. Res Publ Assoc Res Nerv Ment Dis; 1986 Jun 20; 64():279-86. PubMed ID: 2873637 [No Abstract] [Full Text] [Related]
38. Monoamine neurotransmitters and the pathophysiology of stroke and central nervous system trauma. Wurtman RJ, Zervas NT. J Neurosurg; 1974 Jan 20; 40(1):34-6. PubMed ID: 4148424 [No Abstract] [Full Text] [Related]